BioSpace News Archive

Increasing preference toward minimally invasive procedures are some key factors driving market revenue growth.

Rising prevalence of non-small cell lung cancer and increased investment in Research & Development (R&D) of new therpaies for the disease is driving market revenue growth.

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced initial results from the Phase 1/2 clinical trial of its COVID-Influenza Combination Vaccine (CIC).

NotiSphere has been awarded a contract with Vizient, Inc. for its recall management solution, a digital platform that allows medical device suppliers to share product alerts instantly with their customers.

HKW, a middle-market private equity firm focused on growth-oriented companies; today announced that its portfolio company, Infab, LLC (“Infab”), has acquired the glove division of International Biomedical, Ltd.

Sonendo, Inc. announced the launch of its CleanFlow™ procedure instrument, which is designed to work with Sonendo’s GentleWave System to provide a less invasive and less painful alternative to traditional root canal therapy.

CytRx Corporation announced it has partnered with oncology development expert Gilad Gordon, MD to assist the Company in developing its next-generation LADR drugs toward first-in-human clinical trials.

Genovac, a leading contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures antibodies for therapeutic, diagnostic, and research market segments, and Carterra, Inc., the world leader in label-free high-throughput antibody screening and characterization, today announced that Genovac has acquired Carterra’s LSA platform for use in its discovery services.

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its first-quarter 2022 financial results and business highlights.

Nanalysis Scientific Corp. announces that on Thursday, April 28, 2022 the Company will put out their fourth quarter and full year results release for year ending December 31, 2021.